IBRX in the 13F filings
Immunitybio Inc · CUSIP 45256X103
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 21
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 0 listed it in both
- Shares listed
- 29,180,080
- combined, among listed positions
- Reported value
- $222m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 16 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,906,614.
Managers listing IBRX in Q1 2026
21 of 21 holders
Largest increases and reductions, by shares
Increases
- D. E. Shaw & Co.new position · 12,571,597 shares now+12,571,597
- Voloridge Investment Management LLCnew position · 2,927,552 shares now+2,927,552
- Millennium Management LLCexisting position · 1,420,244 shares now+1,301,816
- Tudor Investment Corpnew position · 573,021 shares now+573,021
- T. Rowe Price Associates Incexisting position · 294,831 shares now+136,589
Reductions
- Jane Street Group LLCexisting position · 704,232 shares now-13,519,992
- Susquehanna International Group LLPexisting position · 1,179,276 shares now-2,475,223
- Citadel Advisors LLCexisting position · 305,578 shares now-398,996
- Two Sigma Investments LPexisting position · 4,385,500 shares now-332,343
- ExodusPoint Capital Management LPexisting position · 84,309 shares now-283,572
New positions and exits
New (7)
Exited (5)
- Squarepoint Ops LLCwas $3.0m
- Renaissance Technologies LLCwas $2.4m
- Man Group PLCwas $163k
- Verition Fund Management LLCwas $153k
- Schonfeld Strategic Advisors LLCwas $89k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2024 | 1 | $2.8m | 1 | 0 |
| Q3 2024 | 1 | $1.6m | 1 | 0 |
| Q4 2024 | 1 | $8.8m | 1 | 0 |
| Q1 2025 | 2 | $11m | 2 | 0 |
| Q2 2025 | 1 | $9.1m | 1 | 0 |
| Q3 2025 | 1 | $13m | 1 | 0 |
| Q1 2026 | 3 | $145m | 16 | 10 |
| Q2 2026 | 4 | $235m | 13 | 11 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
IBRX and GILD →IBRX and AMGN →IBRX and ARGX →Choose a stock to compare with IBRX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own IBRX, latest filings →Back to the 13F Explorer →